CSIMarket
 
Quanterix Corporation  (NASDAQ: QTRX)
Other Ticker:  
 
 
Price: $6.9800 $0.06 0.867%
Day's High: $7.03 Week Perf: 4.96 %
Day's Low: $ 6.83 30 Day Perf: 34.23 %
Volume (M): 384 52 Wk High: $ 16.74
Volume (M$): $ 2,677 52 Wk Avg: $9.82
Open: $6.85 52 Wk Low: $4.05



 Market Capitalization (Millions $) 270
 Shares Outstanding (Millions) 39
 Employees 471
 Revenues (TTM) (Millions $) 135
 Net Income (TTM) (Millions $) -48
 Cash Flow (TTM) (Millions $) 31
 Capital Exp. (TTM) (Millions $) 3

Quanterix Corporation
Quanterix Corp is a biotech company that focuses on the development and commercialization of ultra-sensitive digital biomarker analysis solutions.
The company was founded in 2007 by David Walt, who is a pioneer in microarray technology.
Quanterix Corp aims to revolutionize the way diseases are detected and measured by providing accurate and precise biomarker measurements that can help diagnose and treat diseases at an earlier stage.
The company's flagship product is the Simoa system, which is a fully automated digital immunoassay platform that can detect and measure low-abundance biomolecules with unprecedented sensitivity.
Simoa uses single-molecule detection technology to accurately quantify proteins, DNA, and RNA molecules in biological samples, allowing scientists and clinicians to gain new insights into disease mechanisms and improve disease diagnosis and treatment.
Quanterix Corp's technology has a wide range of applications, including oncology, neurology, cardiology, infectious diseases, inflammation, and autoimmune diseases.
The company collaborates with leading academic institutions, pharmaceutical companies, and diagnostic companies to validate its technology and develop innovative diagnostic assays.
Quanterix Corp has received numerous awards for its technology, including being named a Technology Pioneer by the World Economic Forum, one of the 50 Smartest Companies by MIT Technology Review, and one of the Top 10 Innovations of the Year by The Scientist magazine.
The company is headquartered in Billerica, Massachusetts, and has offices and subsidiaries in Europe and Asia.


   Company Address: 900 Middlesex Turnpike Billerica 1821 MA
   Company Phone Number: 301-9400   Stock Exchange / Ticker: NASDAQ QTRX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
A        1.85% 
BIO        3.11% 
BRKR        1.56% 
ILMN        6.34% 
MTD        2.07% 
RVTY        3.57% 
• View Complete Report
   



Business Update

Quanterix Elevates Biomarker Detection with Groundbreaking DBS Kit Amid Regulatory Challenges

Published Tue, Apr 1 2025 9:06 AM UTC

Quanterix Elevates Biomarker Detection with Groundbreaking DBS Kit Amid Regulatory Challenges In an era where precision in biomedical research is paramount, Quanterix Corporation (NASDAQ: QTRX) is making significant strides to revolutionize the field of biomarker detection. The company recently showcased its innovations at the International Conference on Alzheimer?s and Park...

Business Update

Quanterix Reports Impressive Q4 2024 Revenue Growth of 11%, Outpacing Industry Peers Despite Financial Setbacks,

Published Tue, Mar 18 2025 11:30 AM UTC

Quanterix Corporation Reports Strong Financial Growth Amid Industry Challenges: A Q4 2024 Analysis In a notable demonstration of resilience and strategic execution, Quanterix Corporation (NASDAQ: QTRX), a leader in ultra-sensitive biomarker detection, announced its financial results for the fourth quarter of 2024, spotlighting an 11% revenue growth. This achievement marks th...

Business Update

Quanterix A Compliance Quagmire Dims Market Prospects for beleaguered biotech firm,

Published Mon, Nov 25 2024 12:47 AM UTC

Quanterix Faces Nasdaq Compliance Challenge Amidst Market Struggles In a rather somber turn of events for Quanterix Corporation, the biotechnology firm based in Billerica, Massachusetts, has been formally notified by The Nasdaq Stock Market LLC of its non-compliance with listing regulations. As of November 21, 2024, Quanterix received a Notice indicating that the company fai...

Business Update

Quanterix Faces Nasdaq Compliance Challenge Amid Financial Reporting Delays

Published Sat, Nov 23 2024 2:48 AM UTC

Quanterix Corporation, a prominent player in the diagnostics industry, finds itself navigating regulatory hurdles after receiving a compliance notice from Nasdaq. On November 21, 2024, the company was informed that it has failed to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024. This omission places it in violation of Nasdaq Listing Rule 5250...

Business Update

Quanterixs New Alzheimers Diagnostic Test Launch Amid Market Competition,

Published Tue, Oct 1 2024 12:47 AM UTC

Quanterix Commercializes p-Tau 217 Test Kit Amid Competitive Market Landscape Quanterix Corporation (NASDAQ: QTRX), a leader in ultrasensitive biomarker detection technology, has made significant strides in advancing diagnostic testing for Alzheimer?s Disease (AD). The company announced the commercial release of its Simoa p-Tau 217 Planar Kit, marking an important step forwa...







Quanterix's Segments
Product revenue    70.5 % of total Revenue
Product revenue North America    39.88 % of total Revenue
Product revenue EMEA    17.72 % of total Revenue
Product revenue Asia Pacific    12.91 % of total Revenue
Instruments    8.92 % of total Revenue
Instruments North America    2.76 % of total Revenue
Instruments EMEA    1.23 % of total Revenue
Instruments Asia Pacific    4.92 % of total Revenue
Consumable and other products    61.59 % of total Revenue
Consumable and other products North America    37.12 % of total Revenue
Consumable and other products EMEA    16.48 % of total Revenue
Consumable and other products Asia Pacific    7.99 % of total Revenue
Service and other revenue    29.79 % of total Revenue
Service and other revenue North America    23.38 % of total Revenue
Service and other revenue EMEA    4.84 % of total Revenue
Service and other revenue Asia Pacific    1.57 % of total Revenue
Research services    19.04 % of total Revenue
Research services North America    17.02 % of total Revenue
Research services EMEA    1.12 % of total Revenue
Research services Asia Pacific    0.9 % of total Revenue
Service-type warranties    8.82 % of total Revenue
Service-type warranties North America    5.13 % of total Revenue
Service-type warranties EMEA    3.04 % of total Revenue
Service-type warranties Asia Pacific    0.65 % of total Revenue
Other services    1.93 % of total Revenue
Other services North America    1.23 % of total Revenue
Other services EMEA    0.69 % of total Revenue
Other services Asia Pacific    0.01 % of total Revenue
Collaboration and license revenue    2.62 % of total Revenue
Collaboration and license revenue North America    2.62 % of total Revenue
Grant revenue    0.2 % of total Revenue
Reportable Segment    102.92 % of total Revenue
Reportable Grant revenue    0.2 % of total Revenue

  Quanterix Outlook

On November 13 2024 the Quanterix provided following guidance

nnQuanterix Corporation Issues Preliminary Financial Results for Q3 2024nn

BILLERICA, Mass. ? Quanterix Corporation (NASDAQ: QTRX), a pioneering company dedicated to advancing scientific exploration via ultra-sensitive biomarker detection technologies, has released its preliminary financial results for the third quarter ending September 30, 2024. In addition, the company has reaffirmed its financial guidance for the full year of 2024. However, the specific revenue and profit figures pertaining to this guidance were not disclosed in the announcement.

Despite this omission, Quanterix remains focused on sustaining its robust momentum in the market. The company also revealed plans to restate ce...





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com